surveyAlzheimer’s Foundation of AmericaAlzheimer’s 调查老年痴呆症基金会的美国-阿尔茨海默氏症.doc

Harris Interactive Inc., J29688 PAGE 3 ICAN 2: Investigating Caregivers’ Attitudes and Needs February 9, 2007 Conducted on Behalf of:The Alzheimers Foundation of America (AFA) and sponsored by Forest Pharmaceuticals, Inc. Fieldwork: January 9 to February 6 Project Managers: Felisha Lewis Senior Research Director Introduction ICAN 2: Investigating Caregivers’ Attitudes and Needs was conducted by Harris Interactive on behalf of the Alzheimer’s Foundation of America (AFA) and sponsored by Forest Pharmaceuticals, Inc. The purpose of this study was to assess any cultural differences in caregivers’ attitudes and feelings towards caregiving including access to support groups, knowledge and education. This report highlights findings among a nationally representative sample of caregivers who are involved in care and treatment decisions on behalf of a relative or friend with Alzheimer’s disease. Primary topics covered in this survey include: Obstacles that may have delayed getting a diagnosis of Alzheimer’s disease Attitudes towards and knowledge of Alzheimer’s disease Access to support and advocacy groups Impact of caregiving responsibilities on the caregiver’s own family and life Survey Method and Sample Harris Interactive surveyed a cross section of 655 U.S. caregivers who are involved in care and treatment decisions on behalf of a relative or friend with Alzheimer’s disease during January 2007. Respondents were recruited from a sample purchased from an outside vendor and the Harris Interactive Online Panel (HPOL). All interviews were conducted via the telephone. Respondents recruited from the panel were invited to participate via email and provided a toll free number to participate. Interviews averaged 25 minutes in length. A detailed survey methodology appears in Appendix A and the survey questionnaire in Appendix B of this report. Findings I. OBSTACLES TO DIAGNOSIS On average, most patients in this study had been diagnosed with Alzheimer’s disease roughly two yea